Dublin, Dec. 07, 2015 (GLOBE NEWSWIRE) -- Research and Markets ( http://www.researchandmarkets.com/research/zg...iagnostics ) has announced the addition of the "Immunodiagnostics Market in China 2016-2020" report to their offering.
This comprehensive report provides a detailed understanding of the various factors to affect the immunodiagnostics market in China over the coming years. The market is expected to stay healthy and to grow at an impressive CAGR of around 18% by 2020. The introduction of stringent healthcare reforms, growing preference for local manufacture of diagnostic devices, and rapidly increasing competition are some of the significant factors that augment growth in this market during the forecast period. The immunodiagnostic market in the China is consolidated due to the presence of numerous small, medium, and large vendors. The vendors in this market compete on the basis of product differentiation, application differentiation, portfolio, and pricing to gain maximum market traction during the forecast period.
Questions Answered:
- What will the market size and the growth rate be in 2020?
- What are the key factors driving the immunodiagnostic market in the China?
- What are the key Market trends impacting the growth of the immunodiagnostic market in the China?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the vendors in the immunodiagnostic market in the China?
- What are the key outcomes of the five forces analysis of the immunodiagnostic market in the China?
Companies Mentioned:
- Abbott Diagnostics
- Beckman Coulter Diagnostics
- Roche Diagnostics
- Siemens Healthcare Diagnostics
- BioSino Bio-technology & Science
- DiaSorin
- Immunodiagnostic System Holdings (IDS)
- Mindray Medical International
- Shanghai Kehua Bio-engineering
- Sichuan Maccura Biotechnology
Report Structure: PART 01: Executive summary PART 02: Scope of the report PART 03: Market research methodology PART 04: Introduction PART 05: Healthcare system in China PART 06: Market landscape PART 07: Market segmentation by product type PART 08: Market segmentation by analyzer type PART 09: Market segmentation by mode of operation PART 10: Market segmentation by technology PART 11: Market drivers PART 12: Impact of drivers PART 13: Market challenges PART 14: Impact of drivers and challenges PART 15: Market trends PART 16: Vendor landscape PART 17: Key vendor analysis PART 18: Appendix PART 19: About the Autho
For more information visit http://www.researchandmarkets.com/research/zg...iagnostics
CONTACT: Research and Markets Laura Wood, Senior Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 Sector: In Vitro Diagnostics
